Search
for
Sort by
Research 91–120 of 374
- Frontal Alopecia after Repeated Botulinum Toxin Type A Injections for Forehead Wrinkles: An Underestimated Entity?
- Inconsolable Crying in Infants: Differential Diagnosis in the Pediatric Emergency Department
- DRUG‐ASSOCIATED ALOPECIA
- Anticonvulsant-Induced Cutaneous Reactions
- Vitamin D: A Bridging Element for Wellness; A Case Study on Vitamin D Deficiency and its Association with Alopecia Areata and Other Conditions
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse cutaneous effects of psychotropic medications
- Syphilis: today
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Steroid Hormones of Reproduction and Sexual Development
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Tinea Capitis: An Overview with Emphasis on Management
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Finasteride Treatment of Hair Loss in Women
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Skin diseases in consequence of endocrine alterations
- Psychoactive drugs and skin
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Dermatological drugs, topical agents, and cosmetics
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Impact of culture medium on antifungal susceptibility results for Microsporum canis and Nannizzia gypsea: A comparative study of disc diffusion and E-test performance
- A hair-follicle reconstructed in vitro immunocompetent skin model for prediction of the sensitizing potential of chemicals
- Low Level Laser and Light Therapy
- Drug Information Analysis Service
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Study of Skin Expression of MicroRNA-146a in Patients with Alopacia Areata